0001493152-24-002571.txt : 20240117 0001493152-24-002571.hdr.sgml : 20240117 20240117090513 ACCESSION NUMBER: 0001493152-24-002571 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240116 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240117 DATE AS OF CHANGE: 20240117 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TRxADE HEALTH, INC CENTRAL INDEX KEY: 0001382574 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39199 FILM NUMBER: 24536867 BUSINESS ADDRESS: STREET 1: 2420 BRUNELLO TRACE CITY: LUTZ STATE: FL ZIP: 33558 BUSINESS PHONE: (800) 261 0281 MAIL ADDRESS: STREET 1: 2420 BRUNELLO TRACE CITY: LUTZ STATE: FL ZIP: 33558 FORMER COMPANY: FORMER CONFORMED NAME: TRXADE GROUP, INC. DATE OF NAME CHANGE: 20140207 FORMER COMPANY: FORMER CONFORMED NAME: XCELLINK INTERNATIONAL INC. DATE OF NAME CHANGE: 20081230 FORMER COMPANY: FORMER CONFORMED NAME: Bluebird Exploration Co. DATE OF NAME CHANGE: 20061204 8-K 1 form8-k.htm
false 0001382574 0001382574 2024-01-16 2024-01-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(D) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

Date of report (Date of earliest event reported): January 16, 2024

 

 

TRxADE HEALTH, INC.

(Exact name of registrant as specified in its charter)

 

 

Delaware   001-39199   46-3673928

(State or other jurisdiction

of incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification No.)

 

2420 Brunello Trace, Lutz, Florida   33558
(Address of principal executive offices)   (Zip Code)

 

(800) 261-0281

(Registrant’s telephone number, including area code)

 

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class   Trading Symbol(s)   Name of Each Exchange on Which Registered
Common Stock, par value $0.00001 per share   MEDS   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 8.01 Other Events.

 

On January 16, 2024 TRxADE HEALTH Inc., a Delaware corporation (the “Company”), filed with the Securities and Exchange Commission (the “SEC”) its Quarterly Report on Form 10-Q for the period ending September 30, 2023 (the “Form 10-Q”).

 

As previously reported on a Current Report on Form 8-K filed on November 21, 2023 the Company received a standard notice of noncompliance from the Nasdaq Listing Qualifications Department (“Nasdaq”) indicating that, as a result of not having timely filed its Form 10-Q, the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of all required periodic financial reports with the SEC.

 

The Company believes it has now regained compliance with Nasdaq Listing Rule 5250(c)(1) with the filing of its Form 10-Q.

 

Item 9.01. Exhibits

 

Exhibit No.   Description of Exhibit

99.1

  

Press Release

104   Inline XBRL for the cover page of this Current Report on Form 8-K

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  TRxADE HEALTH, INC.
     
  By: /s/ Suren Ajjarapu
  Name: Suren Ajjarapu
  Title: Chief Executive Officer
     
Dated: January 17, 2024    

 

 

 

 EX-99.1 2 ex99-1.htm

 

Exhibit 99.1

 

Trxade Health, Inc.

 

Trxade health, Inc files its 3Q 10Q

 

TAMPA, FL, January 17, 2024 (GLOBE NEWSWIRE) — TRxADE HEALTH, INC. (NASDAQ: MEDS) (“TRxADE”), a parent company of pharmaceutical business-to-business exchange platform, announced today that it filed its Quarterly Report on Form 10-Q for the period ended September 30, 2023 (the “Form 10-Q”).

 

On November 21, 2023, the Company received a standard notice of noncompliance from the Nasdaq Listing Qualifications Department (“Nasdaq”) indicating that, as a result of not having timely filed its Form 10-Q, the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of all required periodic financial reports with the Securities and Exchange Commission.

 

The Company believes it has now regained compliance with Nasdaq Listing Rule 5250(c)(1) with the filing of its Form 10-Q.

 

About TRxADE HEALTH, INC.

 

TRxADE Health, Inc. is a parent company with various subsidiaries which include the pharmaceutical marketplace https://rx.trxade.com, plant-based food www.superlatus.com.

 

Forward-Looking Statements

 

Certain statements in this press release are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. TRxADE intends that such forward-looking statements be subject to the safe harbors created thereby. Forward-looking statements relate to future events or TRxADE’s future performance or future financial condition. These forward-looking statements are not historical facts but rather are based on current expectations, estimates, and projections about TRxADE, its industry, beliefs, and assumptions. Such forward-looking statements include, but are not limited to, statements regarding TRxADE’s or TRxADE’s management team’s expectations, hopes, beliefs, intentions, or strategies regarding the future, including TRxADE ‘splans for and the potential benefits of the supplier agreement and the products, markets, and expected future performance and market opportunities of TRxADE. In addition, any statements that refer to projections, forecasts, or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. In some cases, you can identify forward-looking statements by the following words: “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “ongoing,” “plan,” “potential,” “predict,” “project,” “should,” or the negative of these terms or other similar expressions, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are subject to a number of risks and uncertainties (some of which are beyond TRxADE’s control) that may cause actual results or performance to be materially different from those expressed or implied by such forward-looking statements. Accordingly, readers should not place undue reliance on any forward-looking statements. These risks include risks relating to agreements with third parties; TRxADE’s ability to raise funding in the future, as needed, and the terms of such funding, including potential dilution caused thereby; TRxADE’s ability to continue as a going concern; security interests under certain of TRxADE’s credit arrangements; TRxADE’s ability to maintain the listing of its common stock on The Nasdaq Capital Market; claims relating to alleged violations of intellectual property rights of others; the outcome of any current legal proceedings or future legal proceedings that may be instituted against TRxADE; unanticipated difficulties or expenditures relating to TRxADE’s business plan; and those risks detailed in TRxADE’s most recent Annual Report on Form 10-K and subsequent reports filed with the Securities and Exchange Commission. Forward-looking statements speak only as of the date they are made. TRxADE undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise that occur after that date, except as otherwise provided by law.

 

Investor Contact:

 

Skyline Corporate Communications Group, LLC

Scott Powell, President

One Rockefeller Plaza, 11th Floor

New York, NY 10020

Office: (646) 893-5835

Email: info@skylineccg.com

 

 

 

 GRAPHIC 3 ex99-1_001.jpg begin 644 ex99-1_001.jpg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end EX-101.SCH 4 meds-20240116.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 5 meds-20240116_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 6 meds-20240116_pre.xml XBRL PRESENTATION FILE XML 7 R1.htm IDEA: XBRL DOCUMENT v3.23.4
Cover
Jan. 16, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jan. 16, 2024
Entity File Number 001-39199
Entity Registrant Name TRxADE HEALTH, INC.
Entity Central Index Key 0001382574
Entity Tax Identification Number 46-3673928
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 2420 Brunello Trace
Entity Address, City or Town Lutz
Entity Address, State or Province FL
Entity Address, Postal Zip Code 33558
City Area Code (800)
Local Phone Number 261-0281
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.00001 per share
Trading Symbol MEDS
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 8 form8-k_htm.xml IDEA: XBRL DOCUMENT 0001382574 2024-01-16 2024-01-16 iso4217:USD shares iso4217:USD shares false 0001382574 8-K 2024-01-16 TRxADE HEALTH, INC. DE 001-39199 46-3673928 2420 Brunello Trace Lutz FL 33558 (800) 261-0281 false false false false Common Stock, par value $0.00001 per share MEDS NASDAQ false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.4 html 1 22 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://trxadehealth.com/role/Cover Cover Cover 1 false false All Reports Book All Reports form8-k.htm meds-20240116.xsd meds-20240116_lab.xml meds-20240116_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form8-k.htm": { "nsprefix": "MEDS", "nsuri": "http://trxadehealth.com/20240116", "dts": { "inline": { "local": [ "form8-k.htm" ] }, "schema": { "local": [ "meds-20240116.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "meds-20240116_lab.xml" ] }, "presentationLink": { "local": [ "meds-20240116_pre.xml" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 22 }, "report": { "R1": { "role": "http://trxadehealth.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-01-16", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-01-16", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true } } }, "tag": { "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 15 0001493152-24-002571-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-24-002571-xbrl.zip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end